Cite
Ortiz-Cuaran S, Mezquita L, Swalduz A, et al. Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with . Clin Cancer Res. 2020;26(23):6242-6253doi: 10.1158/1078-0432.CCR-20-1037.
Ortiz-Cuaran, S., Mezquita, L., Swalduz, A., Aldea, M., Mazieres, J., Leonce, C., Jovelet, C., Pradines, A., Avrillon, V., Chumbi Flores, W. R., Lacroix, L., Loriot, Y., Westeel, V., Ngo-Camus, M., Tissot, C., Raynaud, C., Gervais, R., Brain, E., Monnet, I., Giroux Leprieur, E., Caramella, C., Mahier-Aït Oukhatar, C., Hoog-Labouret, N., de Kievit, F., Howarth, K., Morris, C., Green, E., Friboulet, L., Chabaud, S., Guichou, J. F., Perol, M., Besse, B., Blay, J. Y., Saintigny, P., & Planchard, D. (2020). Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with . Clinical cancer research : an official journal of the American Association for Cancer Research, 26(23), 6242-6253. https://doi.org/10.1158/1078-0432.CCR-20-1037
Ortiz-Cuaran, Sandra, et al. "Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with ." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26,23 (2020): 6242-6253. doi: https://doi.org/10.1158/1078-0432.CCR-20-1037
Ortiz-Cuaran S, Mezquita L, Swalduz A, Aldea M, Mazieres J, Leonce C, Jovelet C, Pradines A, Avrillon V, Chumbi Flores WR, Lacroix L, Loriot Y, Westeel V, Ngo-Camus M, Tissot C, Raynaud C, Gervais R, Brain E, Monnet I, Giroux Leprieur E, Caramella C, Mahier-Aït Oukhatar C, Hoog-Labouret N, de Kievit F, Howarth K, Morris C, Green E, Friboulet L, Chabaud S, Guichou JF, Perol M, Besse B, Blay JY, Saintigny P, Planchard D. Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with . Clin Cancer Res. 2020 Dec 01;26(23):6242-6253. doi: 10.1158/1078-0432.CCR-20-1037. Epub 2020 Aug 28. PMID: 32859654.
Copy
Download .nbib